Similar articles

• [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].

  Haase W. Haase W. Strahlenther Onkol. 1996 Feb;172(2):109-10. Strahlenther Onkol. 1996. PMID: 8669043 Clinical Trial. German. No abstract available.
• The problem of ductal carcinoma in situ of the breast.

  Fentiman IS. Fentiman IS. Ann Chir Gynaecol. 1992;81(4):334-6. Ann Chir Gynaecol. 1992. PMID: 1336650
• [The multicentricity of minimal breast cancer. The observations and therapeutic implications apropos 30 cases].

  Cervi GC, Giulini SM, Pouchè A, Coniglio A, Galvani G, Tambussi U, Floriani M, Tiberio G. Cervi GC, et al. Minerva Med. 1989 Aug;80(8):895-9. Minerva Med. 1989. PMID: 2552356 Italian. No abstract available.
• Therapy of in situ cancer.

  Recht A, Connolly JL, Schnitt SJ, Harris JR. Recht A, et al. Hematol Oncol Clin North Am. 1989 Dec;3(4):691-708. Hematol Oncol Clin North Am. 1989. PMID: 2558105 Review.
• Current management of noninvasive (in situ) breast cancer.

  Silverstein MJ. Silverstein MJ. Adv Surg. 2000;34:17-41. Adv Surg. 2000. PMID: 10997214 Review. No abstract available.